HLA-DQgene polymorphisms are associated with hepatocellular carcinoma and hepatitis B surface antigen in chronic hepatitis B virus infection
Autor: | Toru Nishikawa, Naoto Kawabe, Kentaro Yoshioka, Senju Hashimoto, Naohiro Ichino, Masashi Ohki, Takuji Nakano, Tomoki Takamura, Aiko Fukui, Sayuri Nomura, Keisuke Osakabe, Takamitsu Kurashita, Yuka Ochi, Kazunori Nakaoka, Toshiki Kan, Michihito Murao |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
HBsAg Hepatology Nucleoside analogue business.industry virus diseases Hepatitis B medicine.disease digestive system diseases 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Infectious Diseases HBeAg Antigen Hepatocellular carcinoma Genotype Immunology HLA-DQ medicine 030211 gastroenterology & hepatology business medicine.drug |
Zdroj: | Hepatology Research. 47:755-766 |
ISSN: | 1386-6346 |
Popis: | Aim Genome-wide association studies have revealed that single nucleotide polymorphism (SNP) of human leukocyte antigen (HLA)-DQ is associated with the clearance of hepatitis B surface antigen (HBsAg) in acute hepatitis B virus (HBV) infection. We examined the effects of the SNPs on the development of hepatocellular carcinoma (HCC) and markers of HBV in chronic HBV infection. Methods The SNPs of HLA-DQ (rs2856718 and rs7453920) were determined in 299 patients with chronic HBV infection. Results In 224 HBV envelope antigen (HBeAg)-negative patients, those with rs2856718 genotype AG + GG had significantly lower hepatitis B core-related antigen levels (p = 0.0184), less frequent treatment with nucleotide/nucleoside analogs (NAs) (p = 0.0433), and less frequent HCC development (p = 0.0256) than those with genotype AA. Multivariate analysis selected age (p = 0.0460), platelet (p = 0.0481), γ-GTP (p = 0.0030) and NAs treatment (p = 0.0003) as factors independently associated with HCC development. HBeAg-negative patients with rs7453920 genotype GG had significantly lower HBsAg levels (p |
Databáze: | OpenAIRE |
Externí odkaz: |